Healthcare provider profile · identity verified

Erin Mclaughlin, MD

Family Practice · RENTON, WA · NPI 1932555620

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	677	196
Amlodipine Besylate	Amlodipine Besylate	390	116
Lisinopril	Lisinopril	343	99
Levothyroxine Sodium	Levothyroxine Sodium	333	88
Gabapentin	Gabapentin	249	68
Omeprazole	Omeprazole	234	67
Losartan Potassium	Losartan Potassium	210	60
Metoprolol Succinate	Metoprolol Succinate	197	60
Hydrochlorothiazide	Hydrochlorothiazide	175	52
Metformin Hcl	Metformin Hcl	171	43
Metformin Hcl Er	Metformin Hcl	166	51
Rosuvastatin Calcium	Rosuvastatin Calcium	158	43
Trazodone Hcl	Trazodone Hcl	141	43
Sertraline Hcl	Sertraline Hcl	127	41
Simvastatin	Simvastatin	127	43
Furosemide	Furosemide	125	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	24
Duloxetine Hcl	Duloxetine Hcl	95	20
Tamsulosin Hcl	Tamsulosin Hcl	91	33
Alendronate Sodium	Alendronate Sodium	87	28
Jardiance	Empagliflozin	85	25
Pantoprazole Sodium	Pantoprazole Sodium	85	26
Famotidine	Famotidine	80	19
Pravastatin Sodium	Pravastatin Sodium	79	25
Albuterol Sulfate Hfa	Albuterol Sulfate	77	29
Ozempic	Semaglutide	77	23
Glipizide	Glipizide	72	21
Cephalexin	Cephalexin	66	34
Allopurinol	Allopurinol	64	16
Eliquis	Apixaban	64	18
Estradiol	Estradiol	64	22
Farxiga	Dapagliflozin Propanediol	63	15
Oxycodone Hcl	Oxycodone Hcl	59	11
Fluticasone Propionate	Fluticasone Propionate	57	25
Olmesartan Medoxomil	Olmesartan Medoxomil	57	20
Potassium Chloride	Potassium Chloride	57	14
Escitalopram Oxalate	Escitalopram Oxalate	56	11
Tramadol Hcl	Tramadol Hcl	54	13
Baclofen	Baclofen	53	suppressed
Carvedilol	Carvedilol	51	14
Prednisone	Prednisone	51	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	15
Fluoxetine Hcl	Fluoxetine Hcl	48	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	15
Diclofenac Sodium	Diclofenac Sodium	45	30
Glipizide Er	Glipizide	45	16
Naproxen	Naproxen	44	34
Venlafaxine Hcl Er	Venlafaxine Hcl	44	12
Azelastine Hcl	Azelastine Hcl	43	14
Meloxicam	Meloxicam	43	16
Citalopram Hbr	Citalopram Hydrobromide	42	11
Atenolol	Atenolol	39	13
Ipratropium Bromide	Ipratropium Bromide	38	15
Lamotrigine	Lamotrigine	38	suppressed
Oxcarbazepine	Oxcarbazepine	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	17
Benazepril Hcl	Benazepril Hcl	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Aripiprazole	Aripiprazole	32	11
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	32	suppressed
Bupropion Xl	Bupropion Hcl	32	12
Buspirone Hcl	Buspirone Hcl	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Hydrocortisone	Hydrocortisone	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Finasteride	Finasteride	30	11
Montelukast Sodium	Montelukast Sodium	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Ketoconazole	Ketoconazole	28	17
Quetiapine Fumarate	Quetiapine Fumarate	28	12
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Fluconazole	Fluconazole	25	16
Synthroid	Levothyroxine Sodium	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Xarelto	Rivaroxaban	23	suppressed
Ciclopirox	Ciclopirox	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Colchicine	Colchicine	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Lovastatin	Lovastatin	20	suppressed
Methenamine Hippurate	Methenamine Hippurate	20	suppressed
Nyamyc	Nystatin	20	suppressed
Ondansetron Odt	Ondansetron	20	15
Pregabalin	Pregabalin	20	suppressed
Carbamazepine Er	Carbamazepine	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Dantrolene Sodium	Dantrolene Sodium	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Valsartan	Valsartan	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Clotrimazole	Clotrimazole	18	14
Constulose	Lactulose	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Chlorthalidone	Chlorthalidone	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Lactulose	Lactulose	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	15	suppressed
Nystatin	Nystatin	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Cimetidine	Cimetidine	12	suppressed
Combipatch	Estradiol/Norethindrone Acet	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error